XML 50 R38.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Weighted-average assumptions used to estimate fair value of restricted stock units Inputs and assumptions used to calculate the fair value are shown in the table below. The fair value of these RSUs is expensed over the vesting period using the straight-line method or using the graded vesting method when an employee becomes eligible to retain the award at retirement.
Nine Months Ended September 30,20212020
Fair value per stock award$171.63 $94.98 
Grant date stock price$141.59 $83.93 
Assumptions:
Aptar's stock price expected volatility21.40 %23.80 %
Expected average volatility of peer companies50.00 %48.50 %
Correlation assumption58.10 %63.50 %
Risk-free interest rate0.32 %0.31 %
Dividend yield assumption1.02 %1.72 %
Summary of restricted stock unit activity
A summary of RSU activity as of September 30, 2021 and changes during the nine month period then ended is presented below:
Time-Based RSUsPerformance-Based RSUs
UnitsWeighted Average
Grant-Date Fair Value		UnitsWeighted Average
Grant-Date Fair Value
Nonvested at January 1, 2021576,198 $92.47 590,064 $100.27 
Granted143,807 138.89 169,974 152.51 
Vested(220,723)96.13 (72,139)128.66 
Forfeited(3,918)102.54 (32,561)92.26 
Nonvested at September 30, 2021495,364 $108.36 655,338 $111.09 
Schedule of compensation expense, fair value, and intrinsic value related to RSU's
Nine Months Ended September 30,20212020
Compensation expense$29,493 $24,497 
Fair value of units vested29,671 11,188 
Intrinsic value of units vested39,752 13,475 
Summary of option activity A summary of option activity under our stock plans during the nine months ended September 30, 2021 is presented below:
Stock Awards PlansDirector Stock Option Plans
OptionsWeighted Average
Exercise Price		OptionsWeighted Average
Exercise Price
Outstanding, January 1, 20213,998,047 $70.28 99,200 $60.80 
Granted— — — — 
Exercised(841,091)64.57 (47,500)57.40 
Forfeited or expired(10,153)75.46 — — 
Outstanding at September 30, 20213,146,803 $71.79 51,700 $63.91 
Exercisable at September 30, 20213,146,803 $71.79 51,700 $63.91 
Weighted-Average Remaining Contractual Term (Years):
Outstanding at September 30, 20214.32.3
Exercisable at September 30, 20214.32.3
Aggregate Intrinsic Value:
Outstanding at September 30, 2021$153,196 $2,924 
Exercisable at September 30, 2021$153,196 $2,924 
Intrinsic Value of Options Exercised During the Nine Months Ended:
September 30, 2021$65,139 $4,248 
September 30, 2020$44,086 $2,183 
Schedule of compensation expense, and fair value related to options
Nine Months Ended September 30,20212020
Compensation expense (included in SG&A)$185 $1,409 
Compensation expense (included in Cost of sales)42 285 
Compensation expense, Total$227 $1,694 
Compensation expense, net of tax174 1,289 
Grant date fair value of options vested2,421 7,601